Solara Active Pharma Sciences Ltd.(IN:SOLARA)
₹628.40-10.90 (-1.70%)
IN:SOLARA
Solara Active Pharma Sciences Ltd. financials statements
₹628.40
At close:-10.90 (-1.70%)
Want to see IN:SOLARA full AI Analyst Report?
Solara Active Pharma Sciences Ltd. (SOLARA) Ratios
3 Followers
Solara Active Pharma Sciences Ltd. Ratios
IN:SOLARA's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:SOLARA's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.96 | 0.77 | 0.64 | 1.08 | 1.17 |
| Quick Ratio | 0.60 | 0.44 | 0.35 | 0.57 | 0.62 |
| Cash Ratio | 0.06 | 0.00 | 0.01 | 0.01 | 0.04 |
| Solvency Ratio | 0.09 | 0.09 | -0.33 | 0.06 | 0.03 |
| Operating Cash Flow Ratio | 0.07 | 0.23 | 0.09 | 0.14 | -0.23 |
| Short-Term Operating Cash Flow Coverage | 0.11 | 0.32 | 0.12 | 0.20 | -0.33 |
| Net Current Asset Value | ₹ -2.19B | ₹ -4.06B | ₹ -6.14B | ₹ -2.09B | ₹ -1.78B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.29 | 0.36 | 0.43 | 0.35 | 0.35 |
| Debt-to-Equity Ratio | 0.55 | 0.73 | 1.08 | 0.68 | 0.68 |
| Debt-to-Capital Ratio | 0.35 | 0.42 | 0.52 | 0.40 | 0.40 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.09 | 0.10 | 0.14 | 0.16 |
| Financial Leverage Ratio | 1.86 | 2.04 | 2.52 | 1.93 | 1.94 |
| Debt Service Coverage Ratio | 0.29 | 0.27 | -0.36 | 0.21 | 0.14 |
| Interest Coverage Ratio | 0.92 | 3.88 | -3.72 | 0.10 | -0.48 |
| Debt to Market Cap | 0.36 | 0.39 | 0.70 | 0.92 | 0.46 |
| Interest Debt Per Share | 177.14 | 236.16 | 285.49 | 305.45 | 308.05 |
| Net Debt to EBITDA | 3.41 | 3.84 | -3.55 | 6.59 | 12.49 |
| Profitability Margins | |||||
| Gross Profit Margin | 26.71% | 51.21% | -10.08% | 8.75% | 44.19% |
| EBIT Margin | 6.36% | 8.34% | -29.86% | 2.93% | -2.05% |
| EBITDA Margin | 13.64% | 16.07% | -21.89% | 10.68% | 6.25% |
| Operating Profit Margin | 6.36% | 34.72% | -29.89% | 0.60% | -2.62% |
| Pretax Profit Margin | -0.54% | 0.04% | -37.89% | -3.14% | -7.18% |
| Net Profit Margin | -0.54% | 0.04% | -44.02% | -1.55% | -4.58% |
| Continuous Operations Profit Margin | -0.54% | 0.04% | -43.99% | -1.56% | -4.60% |
| Net Income Per EBT | 100.00% | 100.00% | 116.17% | 49.48% | 63.83% |
| EBT Per EBIT | -8.51% | 0.12% | 126.77% | -523.48% | 273.74% |
| Return on Assets (ROA) | -0.32% | 0.02% | -24.13% | -0.76% | -1.97% |
| Return on Equity (ROE) | -0.59% | 0.05% | -60.75% | -1.48% | -3.81% |
| Return on Capital Employed (ROCE) | 6.05% | 34.61% | -34.77% | 0.48% | -1.76% |
| Return on Invested Capital (ROIC) | 4.36% | 22.83% | -19.24% | 0.17% | -0.81% |
| Return on Tangible Assets | -0.38% | 0.03% | -29.20% | -0.89% | -2.31% |
| Earnings Yield | -0.39% | 0.03% | -39.95% | -2.04% | -2.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.12 | 3.93 | 3.70 | 2.66 | 2.59 |
| Payables Turnover | 3.66 | 2.52 | 4.49 | 4.26 | 2.56 |
| Inventory Turnover | 3.16 | 1.97 | 3.90 | 2.33 | 1.23 |
| Fixed Asset Turnover | 1.30 | 1.19 | 1.16 | 1.23 | 1.09 |
| Asset Turnover | 0.59 | 0.58 | 0.55 | 0.49 | 0.43 |
| Working Capital Turnover Ratio | -10.90 | -3.91 | -7.25 | 10.88 | 5.70 |
| Cash Conversion Cycle | 132.98 | 133.22 | 110.83 | 208.11 | 295.37 |
| Days of Sales Outstanding | 116.98 | 92.86 | 98.69 | 137.39 | 140.92 |
| Days of Inventory Outstanding | 115.63 | 185.24 | 93.51 | 156.47 | 296.76 |
| Days of Payables Outstanding | 99.64 | 144.87 | 81.37 | 85.76 | 142.31 |
| Operating Cycle | 232.61 | 278.09 | 192.21 | 293.86 | 437.68 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 13.99 | 55.18 | 27.87 | 43.41 | -67.34 |
| Free Cash Flow Per Share | 2.01 | 44.82 | 17.36 | 12.48 | -125.39 |
| Dividend Paid and CapEx Coverage Ratio | 1.17 | 5.33 | 2.65 | 1.40 | -1.10 |
| Capital Expenditure Coverage Ratio | 1.17 | 5.33 | 2.65 | 1.40 | -1.16 |
| Operating Cash Flow Coverage Ratio | 0.09 | 0.27 | 0.11 | 0.15 | -0.23 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.17 | 0.08 | 0.11 | -0.19 |
| Free Cash Flow Yield | 0.47% | 8.75% | 4.77% | 4.14% | -20.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -253.30 | 3660.36 | -2.50 | -49.00 | -37.94 |
| Price-to-Sales (P/S) Ratio | 1.37 | 1.54 | 1.10 | 0.76 | 1.74 |
| Price-to-Book (P/B) Ratio | 1.50 | 1.81 | 1.52 | 0.72 | 1.45 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 211.37 | 11.43 | 20.94 | 24.17 | -4.90 |
| Price-to-Operating Cash Flow Ratio | 30.42 | 9.29 | 13.04 | 6.95 | -9.12 |
| Price-to-Earnings Growth (PEG) Ratio | 0.19 | -36.57 | -0.00 | 0.79 | 0.30 |
| Enterprise Value Multiple | 13.46 | 13.42 | -8.59 | 13.72 | 40.31 |
| Enterprise Value | 25.13B | 27.69B | 24.23B | 20.90B | 31.97B |
| EV to EBITDA | 13.46 | 13.42 | -8.59 | 13.72 | 40.31 |
| EV to Sales | 1.84 | 2.16 | 1.88 | 1.47 | 2.52 |
| EV to Free Cash Flow | 283.02 | 16.01 | 35.73 | 46.52 | -7.10 |
| EV to Operating Cash Flow | 40.73 | 13.01 | 22.26 | 13.38 | -13.21 |
| Tangible Book Value Per Share | 196.90 | 182.06 | 135.42 | 300.87 | 306.54 |
| Shareholders’ Equity Per Share | 284.05 | 283.70 | 239.11 | 416.77 | 424.27 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.16 | 0.50 | 0.36 |
| Revenue Per Share | 310.38 | 332.83 | 330.00 | 396.32 | 352.90 |
| Net Income Per Share | -1.68 | 0.14 | -145.27 | -6.16 | -16.18 |
| Tax Burden | 1.00 | 1.00 | 1.16 | 0.49 | 0.64 |
| Interest Burden | -0.09 | 0.01 | 1.27 | -1.07 | 3.51 |
| Research & Development to Revenue | 0.00 | 0.03 | 0.04 | 0.03 | 0.05 |
| SG&A to Revenue | 0.20 | 0.16 | 0.02 | 0.16 | 0.19 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Income Quality | -8.33 | 394.11 | -0.22 | -3.49 | 2.66 |
Currency in INR

